138 Pathologic margin involvement and the risk of recurrence inpatients treated with breast-conserving therapy
Irene Gage(Johns Hopkins University), Jay R. Harris(Harvard University), Abram Recht(Beth Israel Deaconess Medical Center), Rebecca Getman(Beth Israel Deaconess Hospital), Asa J. Nixon(Dana-Farber Brigham Cancer Center), Barbara Silvers(Harvard University), James L. Connolly(Beth Israel Deaconess Medical Center), Stuart J. Schnitt(Brigham and Women's Hospital)
International Journal of Radiation Oncology*Biology*Physics
January 1, 1995
Cited by 6
Related Papers
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k
Molecular characterization of the tumor microenvironment in breast cancer
|Cancer Cell|2004|1.3k
Revision of the American Joint Committee on Cancer Staging System for Breast Cancer
|Journal of Clinical Oncology|2002|1.2k
Prognostic Factors in Breast Cancer
|Archives of Pathology & Laboratory Medicine|2000|1.1k
The 2019 World Health Organization classification of tumours of the breast
|Histopathology|2020|1.1k